SBRT21 - Second Annual NYU Langone Long Island Department of Radiation Oncology SBRT for Prostate Cancer Course

Friday, May 7, 2021, 9:00 AM - 4:50 PM, Zoom link will be emailed, Mineola, NY

Stereotactic Body Radiation Therapy (SBRT) has emerged as an exciting, validated, and now standard treatment option for men with localized prostate cancer. This is due to the unique radiobiology of prostate adenocarcinoma coupled with innovation in treatment delivery. Long-term data continues to emerge demonstrating favorable biochemical control coupled with low normal tissue toxicity. Prostate SBRT is now considered a standard of care option for men with localized prostate cancer. This Comprehensive and Interactive Hands-On Course is designed to provide Radiation Oncologists, Urologists, Medical Oncologists, and Nurses with an overview of the long-term data, treatment planning techniques and clinical considerations for optimizing the use of SBRT while minimizing side effects. This course will include didactic lectures, debate, and a treatment planning lab workshop that will involve patient contouring and treatment planning considerations. To promote understanding of the intricacies of treatment, an internationally renowned group of physician scientists has been assembled to lead this discussion.

1. Review treatment modalities for prostate cancer- Prostatectomy vs SBRT and conventional radiotherapy vs SBRT
2. Review new randomized international data exploring whether there are differences in efficacy between surgery, conventionally fractionated radiation, and SBRT for prostate cancer
3. Analysis in the reduction of toxicity to OARs during Prostate SBRT by incorporating the use of hydrogels and other techniques to protect the rectum.
4. Review NCCN updated guidelines in regards to SBRT treatment options for high-risk prostate cancer disease.
5. Explore Prostate SBRT dose escalation and optimal dose.
6. Examine Prostate SBRT treatment differences dependent on treatment techniques and treatment platforms.
7. Discuss management of prostate cancer between disciplines (urology v. radiation oncology).
8. Demonstrate the use of treatment planning and contours to enhance therapeutic effects and optimize outcome.

1. Develop an understanding of treatment modalities for prostate cancer- Prostatectomy vs SBRT and conventional radiotherapy vs SBRT
2. Review new randomized international data exploring whether there are differences in efficacy between surgery, conventionally fractionated radiation, and SBRT for prostate cancer
3. Understanding of the reduction of toxicity to OARs during Prostate SBRT by incorporating the use of hydrogels and other techniques to protect the rectum.
4. Review NCCN updated guidelines in regards to SBRT treatment options for high-risk prostate cancer disease.
5. Evaluation of Prostate SBRT dose.
6. Examine Prostate SBRT treatment differences dependent on treatment techniques and treatment platforms.
7. Analysis in management of prostate cancer between disciplines (urology v. radiation oncology).

AMA Accreditation

NYU Long Island School of Medicine is Accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians through 3/31/2023. Provider #0006392

Nursing Accreditation

NYU Langone Medical Center- Long Island is an approved provider of continuing nursing education by the Northeast Multi-State Division(NEMSD), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider Number: NY009-2020 through December 20, 2023.  

AMA PRA Category 1 Credits™ (6.25 hours), CME - Non-Physician (Attendance) (6.25 hours), ANCC Contact Hours (4.50 hours)